Literature DB >> 24122356

The pivotal role of microRNA-155 in the control of cancer.

Zhaolin Chen1, Taotao Ma, Cheng Huang, Tingting Hu, Jun Li.   

Abstract

microRNAs (miRNAs) are emerging as important gene expression regulators linked to various biological processes at a posttranscriptional level. miRNAs have been known to play important roles in cell proliferation, cell differentiation, and apoptosis. Recently, accumulate studies indicate that up-regulation of miR-155 has been described in several types of human tumors. miR-155 has been considered to act as an oncogene or a tumor suppressor, depending on tumor system. Silencing oncomiRs or gene therapy approaches could be an effective therapeutic approach against tumor. Here we review the current knowledge on the functional role of miR-155 in the control of various cancers.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24122356     DOI: 10.1002/jcp.24492

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  55 in total

1.  Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.

Authors:  James V Michael; Jeremy G T Wurtzel; Guang Fen Mao; A Koneti Rao; Mikhail A Kolpakov; Abdelkarim Sabri; Nicholas E Hoffman; Sudarsan Rajan; Dhanendra Tomar; Muniswamy Madesh; Marvin T Nieman; Johnny Yu; Leonard C Edelstein; Jesse W Rowley; Andrew S Weyrich; Lawrence E Goldfinger
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

Review 2.  The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.

Authors:  Ying Huang; Yang Yang; Yong He; Jun Li
Journal:  Tumour Biol       Date:  2015-10-01

3.  MicroRNA-21 and microRNA-155 promote the progression of Burkitt's lymphoma by the PI3K/AKT signaling pathway.

Authors:  Bo Han; Shuguo Wang; Hongguo Zhao
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

4.  Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function.

Authors:  Shuanzhu Cao; Yanzhou Wang; Jinquan Li; Mingliang Lv; Haitao Niu; Yong Tian
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

5.  miR-155 inhibits the formation of hypertrophic scar fibroblasts by targeting HIF-1α via PI3K/AKT pathway.

Authors:  Xue Wu; Jun Li; Xuekang Yang; Xiaozhi Bai; Jihong Shi; Jianxin Gao; Yan Li; Shichao Han; Yijie Zhang; Fu Han; Yang Liu; Xiaoqiang Li; Kejia Wang; Julei Zhang; Zheng Wang; Ke Tao; Dahai Hu
Journal:  J Mol Histol       Date:  2018-05-21       Impact factor: 2.611

6.  A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients.

Authors:  M-K Chuang; Y-C Chiu; W-C Chou; H-A Hou; E Y Chuang; H-F Tien
Journal:  Leukemia       Date:  2014-11-27       Impact factor: 11.528

7.  Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer.

Authors:  Sinae Kim; Je-keun Rhee; Hyun Ju Yoo; Hee Jin Lee; Eun Ji Lee; Jong Won Lee; Jong Han Yu; Byung Ho Son; Gyungyup Gong; Sung Bae Kim; Shree Ram Singh; Sei Hyun Ahn; Suhwan Chang
Journal:  Cancer Lett       Date:  2014-12-04       Impact factor: 8.679

8.  MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1.

Authors:  Zhijun Ma; Yulan Ma; Qinghua Xia; Yong Li; Ruidong Li; Weilong Chang; Jinhuang Chen; Zhengwei Leng; Kaixiong Tao
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-08       Impact factor: 4.553

9.  Knockdown of LMP1-induced miR-155 sensitizes nasopharyngeal carcinoma cells to radiotherapy in vitro.

Authors:  Yusheng Wang; L E Sun
Journal:  Oncol Lett       Date:  2016-03-31       Impact factor: 2.967

10.  Inhibition of MiR-155 suppresses cell migration in nasopharyngeal carcinoma through targeting ZDHHC2.

Authors:  Yuan-Xue Jiang; Zi-Ming Du; Lin Jiao; Qiong Shao; Sha Fu; Jian-Yong Shao; Xiao-Feng Zhu; Ingemar Ernberg; Yu-Hong Li
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.